Allogene Therapeutics Inc
ALLO · NASDAQ210 East Grand Avenue, South San Francisco, CA, United States, 94080
Dipendenti a tempo pieno
232
Numero identificativo del datore di lavoro
82-3562771
Settore GIC
Health Care
Gruppo GIC
Pharmaceuticals, Biotechnology & Life Sciences
Settore
Biotechnology
Esecutivi di alto livello
Nome
Titolo
Anno di nascita
Dr. Arie S. Belldegrun F.A.C.S., M.D.
Co-Founder & Executive Chairman
1949
Dr. David D. Chang M.D., Ph.D.
Co-Founder, President, CEO & Director
1960
Mr. Joshua A. Kazam
Co-Founder & Director
1977
Mr. Timothy L. Moore Ph.D.
Executive VP & Chief Technical Officer
1961
Dr. Zachary J. Roberts M.D., Ph.D.
Executive VP of Research & Development and Chief Medical Officer
1978
Mr. Geoffrey M. Parker
Executive VP & CFO
1965
Ms. Annie Yoshiyama
Senior VP, Corporate Controller & Principal Accounting Officer
1984
Mr. Earl M. Douglas Esq.
Senior VP, General Counsel, Compliance Officer & Corporate Secretary
1963
Ms. Susan R. Lundeen
Chief People Officer
1966
Ms. Christine Cassiano
Executive VP, Chief Corporate Affairs & Brand Strategy Officer
-
